Abbott Laboratories (BUE:ABT) Cyclically Adjusted FCF per Share: ARS1,438.64 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:ABT Abbott Laboratories BUE:ABT
67 GF Score
Price ARS39,640.00
GF Value ARS51,361.12
Valuation Modestly Undervalued
View Full Analysis

What is Abbott Laboratories Cyclically Adjusted FCF per Share?

Abbott Laboratories BUE:ABT +2.43% 67 Cyclically Adjusted FCF per Share is ARS1,438.64 as of Mar. 2026. GuruFocus rates BUE:ABT with a GF Score™ of 67/100 and a GF Value™ of ARS51,361.12 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Abbott Laboratories's adjusted free cash flow per share for the three months ended in Mar. 2026 was ARS1,466.214. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ARS1,438.64 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Abbott Laboratories's average Cyclically Adjusted FCF Growth Rate was 10.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 8.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Abbott Laboratories was 13.70% per year. The lowest was -4.90% per year. And the median was 7.20% per year.

As of today (2026-07-18), Abbott Laboratories's current stock price is ARS39640.00. Abbott Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ARS1,438.64. Abbott Laboratories's Cyclically Adjusted Price-to-FCF of today is 27.55.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Abbott Laboratories was 48.66. The lowest was 11.59. And the median was 32.57.


Abbott Laboratories  (BUE:ABT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Abbott Laboratories's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=39640.00/1438.64
=27.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Abbott Laboratories was 48.66. The lowest was 11.59. And the median was 32.57.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Abbott Laboratories Cyclically Adjusted FCF per Share Related Terms


Abbott Laboratories Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Cyclically Adjusted FCF per Share Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 149.33 252.94 773.95 1,015.18 1,433.90

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,166.88 1,090.78 1,417.28 1,433.90 1,438.64

BUE:ABT vs SYK, MDT, BSX: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted Price-to-FCF falls into.


BUE:ABT
67GF Score
Abbott Laboratories BUE:ABT
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1466.214/330.2130*330.2130
=1,466.214

Current CPI (Mar. 2026) = 330.2130.

Abbott Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 12.502 241.018 17.129
201609 18.288 241.428 25.013
201612 18.182 241.432 24.868
201703 5.366 243.801 7.268
201706 20.666 244.955 27.859
201709 34.804 246.819 46.563
201712 28.140 246.524 37.693
201803 19.016 249.554 25.162
201806 26.675 251.989 34.956
201809 75.979 252.439 99.387
201812 55.180 251.233 72.527
201903 16.590 254.202 21.551
201906 29.695 256.143 38.282
201909 96.984 256.759 124.729
201912 132.995 256.974 170.899
202003 24.750 258.115 31.663
202006 52.159 257.797 66.811
202009 130.387 260.280 165.420
202012 283.545 260.474 359.461
202103 225.262 264.877 280.826
202106 181.190 271.696 220.214
202109 244.860 274.310 294.761
202112 278.008 278.802 329.273
202203 211.048 287.504 242.399
202206 276.857 296.311 308.533
202209 364.461 296.808 405.480
202212 328.324 296.797 365.290
202303 172.095 301.836 188.274
202306 190.876 305.109 206.581
202309 527.240 307.789 565.652
202312 944.178 306.746 1,016.410
202403 603.832 312.332 638.401
202406 1,459.470 314.175 1,533.973
202409 2,337.636 315.301 2,448.193
202412 2,488.367 315.605 2,603.543
202503 1,138.509 319.799 1,175.584
202506 2,095.314 322.561 2,145.020
202509 3,556.961 324.800 3,616.240
202512 4,369.815 324.054 4,452.868
202603 1,466.214 330.213 1,466.214

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ARS1,438.64 mean?
Abbott Laboratories (BUE:ABT) has a Cyclically Adjusted FCF per Share of ARS1,438.64 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Cyclically Adjusted FCF per Share too high?
Abbott Laboratories' current Cyclically Adjusted FCF per Share is ARS1,438.64. Overall, Abbott Laboratories has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Cyclically Adjusted FCF per Share compare to SYK and MDT?
Abbott Laboratories' Cyclically Adjusted FCF per Share of ARS1,438.64 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Cyclically Adjusted FCF per Share is ARS1,438.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (BUE:ABT) is currently considered Modestly Undervalued. The stock's GF Value™ is ARS51,361.12, compared to a current price of ARS39,640.00 — trading 22.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ARS1,438.64. Abbott Laboratories' overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Abbott Laboratories (BUE:ABT), the current Cyclically Adjusted FCF per Share is ARS1,438.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (BUE:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of ARS39,640.00 is trading 22.8% below its estimated GF Value™ of ARS51,361.12. GuruFocus considers Abbott Laboratories to be Modestly Undervalued.

Key valuation signals for BUE:ABT:

  • Cyclically Adjusted FCF per Share: ARS1,438.64
  • GF Value™: ARS51,361.12 vs. price of ARS39,640.00 (22.8% below fair value)
  • GF Score™: 67/100

No single metric tells the full story. See the BUE:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
67GF Score

Get the complete analysis for BUE:ABT

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS39,640.00
Price
ARS51,361.12
GF Value